assive protection against lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age following maternal immunisation during Pregnancy. For Pregnant individuals A single dose of 0.5 mL should be administered between weeks 24 and 36 of gestation.